Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3635931000168117 | Anzemet 25 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3881161000168114 | Anzemet (dolasetron mesilate monohydrate 25 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4108181000168116 | Anzemet (dolasetron mesylate monohydrate 25 mg) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Anzemet 25 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Anzemet 25 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Anzemet 25 mg tablet | Is a | Anzemet | true | Inferred relationship | Some | ||
| Anzemet 25 mg tablet | Is a | dolasetron mesilate monohydrate 25 mg tablet | true | Inferred relationship | Some | ||
| Anzemet 25 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Anzemet 25 mg tablet | has Australian BoSS | dolasetron mesilate monohydrate | true | Inferred relationship | Some | 733089961 | |
| Anzemet 25 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 733089962 | |
| Anzemet 25 mg tablet | has intended active ingredient | dolasetron | true | Inferred relationship | Some | 733089961 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Anzemet 25 mg tablet, 5 | has TPUU | True | Anzemet 25 mg tablet | Inferred relationship | Some | 1 |
| Anzemet 25 mg tablet, 5, blister pack | has TPUU | True | Anzemet 25 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR